[Form 4] Fluent, Inc. Insider Trading Activity
Patrick Donald Huntley, Chief Executive Officer of Fluent, Inc. (FLNT), reported acquisitions on Form 4 dated 08/19/2025 and signed 08/21/2025. The filing shows two derivative purchases: 14,286 Pre-Funded Warrants at a price of $0.0005 and 14,286 Warrants with a conversion price of $2.21. Each derivative represents the right to acquire 14,286 shares of Common Stock and is reported as direct beneficial ownership.
The pre-funded warrants and warrants are described as immediately exercisable only after stockholder approval of the offering; the warrants have an expiration date of 02/20/2031. The pre-funded warrants will terminate when fully exercised. No other transactions or changes in existing common-stock holdings are disclosed in this filing.
- Insider acquisition disclosed for transparency: CEO reported purchases of pre-funded warrants and warrants
- Clear exercisability and expiration terms provided: pre-funded warrants exercisable after stockholder approval; warrants expire 02/20/2031
- Direct beneficial ownership is stated, enabling straightforward interpretation of holdings
- None.
Insights
TL;DR: CEO acquired paired pre-funded warrants and warrants totaling 28,572 derivative instruments, exercisable after shareholder approval.
The Form 4 documents that the reporting person, Fluent's CEO, acquired 14,286 pre-funded warrants at $0.0005 and 14,286 warrants at a $2.21 exercise price on 08/19/2025, each convertible into 14,286 common shares and reported as direct ownership. The filing states exercisability is contingent on stockholder approval of the offering; the warrants expire 02/20/2031. From a financial-analyst perspective, this is a disclosure of insider participation in an equity-related issuance with deferred exercisability, but the filing does not provide company-level proceeds, dilution percentages, or pre-transaction common-stock totals to assess materiality.
TL;DR: Insider purchase disclosed; exercisability conditioned on shareholder approval, consistent with standard governance procedures.
The filing shows the CEO directly acquired derivative securities tied to common shares, with explicit conditions that the instruments become exercisable only after stockholder approval. The Form 4 properly discloses transaction dates, prices, and expiration, and is signed by the reporting person. The disclosure facilitates transparency about potential future dilution but contains no information about related voting items or the securities' placement details.